Oct 01, 2024
1:15
For every 15 shares held, investors received 1. The price per share adjusted from $0.22 to $0.01.
The split itself did not change the total investment value.
Brainstorm Cell Therapeutics Inc. (BCLI) trades on the Other OTC in the Biotechnology industry.
Brainstorm Cell Therapeutics Inc. company overviewThe latest split shown was on October 1, 2024. It was a 1-for-15 reverse split, so shareholders received 1 share for every 15 they held.
This history records 3 splits between September 4, 2003 and October 1, 2024.